Cargando…
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
BACKGROUND & AIMS: Cholestatic liver injury is associated with c-Jun N-terminal kinases (JNK) activation in distinct cell types. Its hepatocyte-specific function during cholestasis, however, has not yet been established. Therefore, in our present study, we investigated the role of JNK1/2 during...
Autores principales: | Mohamed, Mohamed Ramadan, Haybaeck, Johannes, Wu, Hanghang, Su, Huan, Bartneck, Matthias, Lin, Cheng, Boekschoten, Mark V., Boor, Peter, Goeppert, Benjamin, Rupp, Christian, Strnad, Pavel, Davis, Roger J., Cubero, Francisco Javier, Trautwein, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543210/ https://www.ncbi.nlm.nih.gov/pubmed/37791376 http://dx.doi.org/10.1016/j.jhepr.2023.100854 |
Ejemplares similares
-
Loss of c‐Jun N‐terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
por: Cubero, Francisco Javier, et al.
Publicado: (2020) -
Fibrotic Events in the Progression of Cholestatic Liver Disease
por: Wu, Hanghang, et al.
Publicado: (2021) -
Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease
por: Woitok, Marius Maximilian, et al.
Publicado: (2020) -
JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21
por: Colleoni, B, et al.
Publicado: (2017) -
Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells
por: Zhao, Yan-fang, et al.
Publicado: (2013)